193 related articles for article (PubMed ID: 37858714)
21. MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer.
Mathe A; Scott RJ; Avery-Kiejda KA
Int J Mol Sci; 2015 Nov; 16(12):28347-76. PubMed ID: 26633365
[TBL] [Abstract][Full Text] [Related]
22. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapeutic Stress Influences Epithelial-Mesenchymal Transition and Stemness in Cancer Stem Cells of Triple-Negative Breast Cancer.
Li X; Strietz J; Bleilevens A; Stickeler E; Maurer J
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936348
[TBL] [Abstract][Full Text] [Related]
24. Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-Analysis.
Qattan A; Al-Tweigeri T; Alkhayal W; Suleman K; Tulbah A; Amer S
Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33918859
[TBL] [Abstract][Full Text] [Related]
25. MEF2C and miR-194-5p: New Players in Triple Negative Breast Cancer Tumorigenesis.
Caetano S; Garcia AR; Figueira I; Brito MA
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762600
[TBL] [Abstract][Full Text] [Related]
26. The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis.
Zhang H; Wang J; Yin Y; Meng Q; Lyu Y
Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33443534
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-1246 suppresses the metastasis of breast cancer cells by targeting the DYRK1A/PGRN axis to prevent the epithelial-mesenchymal transition.
Wang P; Chen W; Zhang Y; Zhong Q; Li Z; Wang Y
Mol Biol Rep; 2022 Apr; 49(4):2711-2721. PubMed ID: 35059968
[TBL] [Abstract][Full Text] [Related]
28. Potential Role of miRNA in Metastatic Cascade of Triple-Negative Breast Cancer.
Balkrishna A; Mittal R; Arya V
Curr Cancer Drug Targets; 2021; 21(2):153-162. PubMed ID: 33155912
[TBL] [Abstract][Full Text] [Related]
29. The circRNA circIFI30 promotes progression of triple-negative breast cancer and correlates with prognosis.
Xing L; Yang R; Wang X; Zheng X; Yang X; Zhang L; Jiang R; Ren G; Chen J
Aging (Albany NY); 2020 Jun; 12(11):10983-11003. PubMed ID: 32497020
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer.
Zhao Z; Li L; Du P; Ma L; Zhang W; Zheng L; Lan B; Zhang B; Ma F; Xu B; Zhan Q; Song Y
Theranostics; 2019; 9(5):1401-1416. PubMed ID: 30867840
[No Abstract] [Full Text] [Related]
31. Recent treatment progress of triple negative breast cancer.
Chang-Qing Y; Jie L; Shi-Qi Z; Kun Z; Zi-Qian G; Ran X; Hui-Meng L; Ren-Bin Z; Gang Z; Da-Chuan Y; Chen-Yan Z
Prog Biophys Mol Biol; 2020 Mar; 151():40-53. PubMed ID: 31761352
[TBL] [Abstract][Full Text] [Related]
32. Unveiling Role of MicroRNAs as Treatment Strategy and Prognostic Markers in Triple Negative Breast Cancer.
Balkrishna A; Mittal R; Arya V
Curr Pharm Biotechnol; 2020; 21(15):1569-1575. PubMed ID: 32593278
[TBL] [Abstract][Full Text] [Related]
33. Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype.
Wiese DA; Thaiwong T; Yuzbasiyan-Gurkan V; Kiupel M
BMC Cancer; 2013 Sep; 13():403. PubMed ID: 24004841
[TBL] [Abstract][Full Text] [Related]
34. Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells.
Wu J; Li WZ; Huang ML; Wei HL; Wang T; Fan J; Li NL; Ling R
Biochem Biophys Res Commun; 2017 Jan; 483(1):10-16. PubMed ID: 28069384
[TBL] [Abstract][Full Text] [Related]
35. Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer.
Bhardwaj A; Singh H; Rajapakshe K; Tachibana K; Ganesan N; Pan Y; Gunaratne PH; Coarfa C; Bedrosian I
Oncotarget; 2017 Mar; 8(12):19645-19660. PubMed ID: 28160548
[TBL] [Abstract][Full Text] [Related]
36. Teriflunomide, an immunomodulatory drug, exerts anticancer activity in triple negative breast cancer cells.
Huang O; Zhang W; Zhi Q; Xue X; Liu H; Shen D; Geng M; Xie Z; Jiang M
Exp Biol Med (Maywood); 2015 Apr; 240(4):426-37. PubMed ID: 25304315
[TBL] [Abstract][Full Text] [Related]
37. MicroRNAs in regulation of triple-negative breast cancer progression.
Piasecka D; Braun M; Kordek R; Sadej R; Romanska H
J Cancer Res Clin Oncol; 2018 Aug; 144(8):1401-1411. PubMed ID: 29923083
[TBL] [Abstract][Full Text] [Related]
38. The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression.
Yang R; Xing L; Zheng X; Sun Y; Wang X; Chen J
Mol Cancer; 2019 Jan; 18(1):4. PubMed ID: 30621700
[TBL] [Abstract][Full Text] [Related]
39. Triple-negative breast cancer-derived microvesicles transfer microRNA221 to the recipient cells and thereby promote epithelial-to-mesenchymal transition.
Das K; Paul S; Singh A; Ghosh A; Roy A; Ansari SA; Prasad R; Mukherjee A; Sen P
J Biol Chem; 2019 Sep; 294(37):13681-13696. PubMed ID: 31341019
[TBL] [Abstract][Full Text] [Related]
40. Systematic characterization of non-coding RNAs in triple-negative breast cancer.
Mei J; Hao L; Wang H; Xu R; Liu Y; Zhu Y; Liu C
Cell Prolif; 2020 May; 53(5):e12801. PubMed ID: 32249490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]